Skip to main content

6-K

Stellantis N.V. (STLA)

6-K 2026-04-30 For: 2026-03-31
View Original
Added on July 07, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________________________

FORM 6-K

_______________________________

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

For the month of April 2026

Commission File No. 001-36675

_______________________________

STELLANTIS N.V.

(Translation of Registrant’s Name Into English)

_______________________________

Taurusavenue 1

2132 LS Hoofddorp

The Netherlands

Tel. No.: +31 23 700 1511

(Address of Principal Executive Offices)

_______________________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x Form 40-F o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(1): o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(7): o

The following exhibit is furnished herewith:

Exhibit 99.1    Stellantis N.V. Supplemental Information as of and for the three months ended March 31, 2026

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: April 30, 2026 STELLANTIS N.V.
By: /s/ Joao Laranjo
Name: Joao Laranjo
Title: Chief Financial Officer

Index of Exhibits

Exhibit

Number    Description of Exhibit

99.1        Stellantis N.V. Supplemental Information as of and for the three months ended March 31, 2026

Document

stellantislogoa.jpg

Exhibit 99.1

Income Statement by activity

Unaudited

Three months ended March 31,
2026 2025
(€ million) Stellantis Industrial activities Financial services Stellantis Industrial activities Financial services
Net revenues 38,132 37,028 1,206 35,813 35,171 720
Cost of revenues 33,703 32,749 1,056 32,188 31,679 587
Selling, general and other costs 2,302 2,213 89 2,346 2,253 93
Research and development costs 1,440 1,440 1,433 1,433
Gains/(losses) on disposal of investments (12) (12) (2) (2)
Restructuring costs 98 98 123 123
Share of the profit/(loss) of equity method investees 111 21 90 (37) (126) 89
Operating income/(loss)(1) 688 537 151 (316) (445) 129
Net financial expenses/(income) 150 150 97 97
Profit/(loss) before taxes 538 387 151 (413) (542) 129
Tax expense/(benefit) 161 130 31 (26) 13 (39)
Result from intersegment investments 120 168
Net profit/(loss) 377 377 120 (387) (387) 168
Adjusted operating income/(loss)(1)(2) 960 809 151 327 202 125

______________________________________________________________________________________________________________________________________________

Figures presented for Industrial activities and Financial services include intersegment transactions

(1) Refer to the Stellantis N.V. Interim Report for the three months ended March 31, 2026 - Non-GAAP Financial Measures

(2) The reconciliation of Net profit to Adjusted operating income for the Company is included in the Stellantis N.V. Interim Report for the three months ended March 31, 2026 - Management discussion and analysis - Company results

stellantislogoa.jpg

Statement of Financial Position by activity

Unaudited

At March 31, 2026 At December 31, 2025
(€ million) Stellantis Industrial activities Financial services Stellantis Industrial activities Financial services
Assets
Goodwill and intangible assets with indefinite useful lives 29,766 29,633 133 29,176 29,046 130
Other intangible assets 15,533 15,363 170 15,709 15,540 169
Property, plant and equipment 44,912 32,419 12,493 42,958 32,108 10,850
Equity method investments 7,493 12,646 3,639 7,276 12,336 3,516
Deferred tax assets 6,507 6,428 79 6,383 6,297 86
Inventories 24,960 24,875 85 22,153 22,080 73
Assets sold with a buy-back commitment 3,871 3,871 3,616 3,616
Trade receivables 6,563 6,790 116 5,662 5,812 115
Tax receivables 1,578 1,554 36 1,393 1,464 53
Other assets and prepaid expenses 30,612 16,158 17,432 26,895 13,773 15,937
Financial assets 3,667 3,112 555 3,781 3,235 546
Cash and cash equivalents 31,950 29,615 2,335 30,146 28,198 1,948
Assets held for sale 5 5 5 5
TOTAL ASSETS 207,417 182,469 37,073 195,153 173,510 33,423
Equity and Liabilities
Equity 60,946 60,946 8,747 54,001 54,001 8,576
Employee benefits liabilities 5,261 5,257 4 5,312 5,308 4
Provisions 31,015 30,890 125 32,913 32,809 104
Deferred tax liabilities 1,250 818 432 1,294 874 420
Debt 47,919 24,266 26,414 45,947 25,630 23,035
Trade payables 33,898 34,019 313 29,999 30,082 211
Other financial liabilities 19 12 7 36 19 17
Tax liabilities 930 885 57 911 826 209
Other liabilities 26,179 25,376 974 24,740 23,961 847
Liabilities held for sale
TOTAL EQUITY AND LIABILITIES 207,417 182,469 37,073 195,153 173,510 33,423

________________________________________________________________________________________________________________________________________________

Figures presented for Industrial activities and Financial services include intersegment transactions

stellantislogoa.jpg

Statement of Cash Flows by activity

Unaudited

Three months ended March 31,
2026 2025
(€ million) Stellantis Industrial activities Financial services Stellantis Industrial activities Financial services
Profit/(loss) before taxes 538 507 151 (413) (374) 129
Adjustments for non-cash items:
depreciation and amortization 1,569 1,558 11 1,879 1,866 13
other non-cash items 629 560 69 426 373 53
(gains)/losses on disposals 9 9 (51) (51)
share of the profit/(loss) of equity method investees (111) (141) (90) 37 (42) (89)
Change in provisions and employee benefits liabilities (2,167) (2,172) 5 (1,270) (1,278) 8
Change in carrying amount of leased vehicles (1,273) 94 (1,367) (1,535) 15 (1,550)
Net change in receivables related to financial services activities (1,085) (1,085) (825) (825)
Dividends received 75 163 2 2 2
Income tax received/(paid), net (209) (168) (41) (158) (88) (70)
Changes in working capital (693) (635) (58) (938) (926) (12)
Net cash from/(used in) operating activities (2,718) (225) (2,403) (2,846) (505) (2,341)
Proceeds from disposal of shares in consolidated companies and of investments in non-consolidated companies 10 (16) 26 39 39
Acquisitions of consolidated subsidiaries and equity method and other investments (67) (83) (29) (24) (24)
Proceeds from disposals of property, plant and equipment and intangible assets 16 16 131 131
Investments in property, plant and equipment and intangible assets (1,348) (1,339) (9) (2,329) (2,321) (8)
Change in amounts payable on property, plant and equipment and intangible assets (282) (282) (328) (328)
Changes in loans to joint ventures and associates (108) (108) 289 289
Change in securities 465 387 78 1,177 1,214 (37)
Other changes (1) (2) 1 39 4 35
Net cash from/(used in) investing activities (1,315) (1,427) 67 (1,006) (1,035) 29
Distributions paid (90)
Proceeds from issuance of shares
(Purchases)/sales of treasury shares
Changes in debt and other financial assets and liabilities 631 (2,095) 2,771 2,658 176 2,482
Issuance/(repayment) of hybrid perpetual notes 4,928 4,928
Other changes (35) (35) 2 (2)
Net cash from/(used in) financing activities 5,524 2,798 2,681 2,658 178 2,480
Effect of changes in exchange rates 313 271 42 (294) (306) 12
(Increase)/decrease in cash and cash equivalents included in asset held for sale 168 166 2
Increase/(decrease) in cash and cash equivalents 1,804 1,417 387 (1,320) (1,502) 182
Net cash and cash equivalents at beginning of period 30,146 28,198 1,948 34,100 32,409 1,691
NET CASH AND CASH EQUIVALENTS AT END OF PERIOD 31,950 29,615 2,335 32,780 30,907 1,873

________________________________________________________________________________________________________________________________________________

Figures presented for Industrial activities and Financial services include intersegment transactions